ebook Munafa Stock Market Course + Intraday & FNO calls  

       

532523 announcements Biocon Ltd. announcements and dividends declared BSE

Biocon Ltd. Complete list of announcements declared & dividend announcements by Biocon Ltd. 532523

Biocon Ltd. 532523 listed on BSE and deals in

Announcements and dividends declared by Biocon Ltd. 532523

Biocon shares rise 1% after billionaire Kiran Mazumdar-Shaw names niece as successor
Biocon's chairperson, Kiran Mazumdar-Shaw, has named her niece, Claire Mazumdar, as her successor, sparking a more than 1% jump in the company's shares. Shaw, who founded Biocon over 40 years ago, expressed confidence in Claire's ability to lead the compan
Announcement as on 05 May 2026

Biocon’s Kiran Mazumdar-Shaw chooses niece Claire Mazumdar as successor: Report
Biocon founder Kiran Mazumdar-Shaw has announced her successor. Niece Claire Mazumdar will lead the company. Claire Mazumdar is the founder and CEO of Bicara Therapeutics. She holds advanced degrees and has prior industry experience. Biocon is also undergo
Announcement as on 05 May 2026

With sights on huge gains, Biocon to scale up AI focus
Biopharma major Biocon is significantly scaling up its adoption of artificial intelligence across its operations, from R&D to manufacturing and procurement. This strategic investment aims to achieve substantial cost savings, accelerate drug development
Announcement as on 08 April 2026

Biocon names insider Shreehas Tambe as MD & CEO for 5 years as Siddharth Mittal steps down
Biocon announced a leadership change. Siddharth Mittal will step down as Managing Director and Chief Executive Officer on March 31. He will move to another leadership role within the Biocon Group. Shreehas Pradeep Tambe has been appointed as his successor.
Announcement as on 27 March 2026

Liraglutide still a ‘decent market’ despite Novo’s price moves: Siddharth Mittal, Biocon
Biocon CEO Siddharth Mittal outlines the company's strategy in the competitive GLP-1 market. Focusing on liraglutide's launch in the US and Europe, he highlights opportunities in emerging markets. While semaglutide is a longer-term play, Biocon is active
Announcement as on 26 February 2026

Announcements by Biocon Ltd. first page | Next page | Prev page |

532523 Biocon Ltd. current price & indicator signals

Moving Averages for Biocon Ltd.

  • 5Day Average: 416.39
  • 12Day Average: 415.81
  • 20Day Average: 421.87
  • 50Day Average: 390.48
  • 100Day Average: 383.85
  • 150Day Average: 386.73
  • 200Day Average: 379.72

532523 Indicators & signals

Indicator MACD (12,26,9)

416.75, 411.76, 7.54
Indicator MACD is in positive zone

Indicator ADX (14)

2.54, 17.71, 18.63
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 55
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 532523 Biocon Ltd. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
16 Tue Jun 2026 416.30 414.00 to 423.50 0.01% 0.83 times
15 Mon Jun 2026 416.25 413.25 to 422.95 -0.55% 0.84 times
12 Fri Jun 2026 418.55 414.50 to 422.00 0.42% 0.8 times
11 Thu Jun 2026 416.80 412.30 to 419.90 0.66% 0.62 times
10 Wed Jun 2026 414.05 412.90 to 421.20 -0.53% 0.55 times
09 Tue Jun 2026 416.25 410.00 to 417.20 1.72% 1.88 times
08 Mon Jun 2026 409.20 405.90 to 417.10 -0.69% 0.91 times
05 Fri Jun 2026 412.05 411.45 to 424.85 -0.88% 0.75 times
04 Thu Jun 2026 415.70 405.90 to 419.45 0.79% 1.39 times
03 Wed Jun 2026 412.45 411.45 to 417.20 -1.01% 1.04 times
02 Tue Jun 2026 416.65 411.00 to 428.20 -2.08% 1.22 times
01 Mon Jun 2026 425.50 424.25 to 435.30 -0.64% 2.15 times

Videos related to: 532523 announcements Biocon Ltd. announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

532523 announcements Biocon Ltd. announcements and dividends declared BSE

 

Back to top